title: [Drug-induced immune hemolytic anemia in an 18-month-old patient. Responsible agent: erythromycin].
authors.affiliation: II Pediatria Ospedale Pausilipon, Napoli, Italia.
authors.forename: F
authors.initials: F
authors.lastname: Del Vasto
authors.forename: M F
authors.initials: MF
authors.lastname: Pinta
authors.forename: L
authors.initials: L
authors.lastname: Marchese
authors.forename: M L
authors.initials: ML
authors.lastname: Cimaglia
authors.forename: G
authors.initials: G
authors.lastname: Riverso
authors.forename: M
authors.initials: M
authors.lastname: Ripaldi
authors.forename: G
authors.initials: G
authors.lastname: Fratellanza
mesh_terms: D000744:Anemia, Hemolytic, Autoimmune / Q000139:chemically induced* / Q000188:drug therapy / Q000276:immunology; D000936:Antigen-Antibody Complex; D004917:Erythromycin / Q000009:adverse effects*; D006801:Humans; D007223:Infant; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use
chemical_list: D000936:Antigen-Antibody Complex; D004917:Erythromycin; D008775:Methylprednisolone
vernacular_title: Anemia emolitica immunitaria farmacoindotta in un paziente di 18 mesi. Agente responsabile: eritromicina.